Status:
COMPLETED
SUNLIGHT Study: Online Support Groups for MS to Address COVID-19
Lead Sponsor:
Columbia University
Conditions:
MS (Multiple Sclerosis)
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stress and anxiety can have an adverse impact on health, and the experience of many around the 2020 outbreak of COVID-19 is affecting health and well-being. Individuals with chronic disease such as mu...
Detailed Description
Anxiety is a pervasive and debilitating symptom for individuals with MS, who are at much greater risk for anxiety than the general population. The lifetime prevalence of anxiety in MS is estimated at ...
Eligibility Criteria
Inclusion
- MS Diagnosis
- 18 years or older
Exclusion
- None
Key Trial Info
Start Date :
May 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04379661
Start Date
May 7 2020
End Date
August 31 2020
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032